AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2013
Nov 27, 2013
30237_dirs_2013-11-27_dc03cea2-713e-4601-8778-03783b310a96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2013-11-25
Reporting Person: Brecher Mark E (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-25 | Common Stock | S | 400 | $105.62 | Disposed | 7584.5534 | Direct |
Footnotes
F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: Amount includes 231.6643 shares acquired on June 28, 2013 under the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30